Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.0100 (-3.91%) ($12.9000 - $14.9100) on Fri. Oct. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 65 | Latest Price | $14.0100(-3.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.885% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-10%) UUP(-8%) TLT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 0 () | Intraday Trend | -3.5% | | | |
|
5 Day Moving Average | $14.24(-1.62%) | 10 Day Moving Average | $14.23(-1.55%) | 20 Day Moving Average | $13.79(1.6%) | To recent high | -11.7% | To recent low | 17.5% | Market Cap | $1.041b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |